JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB129192

Anti-Bad (phospho S112) antibody [EPR1891(2)]

Be the first to review this product! Submit a review

|

(25 Publications)

Rabbit Recombinant Monoclonal BAD phospho S112 antibody. Suitable for IP, Dot, WB and reacts with Human, Rat, Synthetic peptide samples. Cited in 25 publications.

View Alternative Names

BBC6, BCL2L8, BAD, Bcl2-associated agonist of cell death, Bcl-2-binding component 6, Bcl-2-like protein 8, Bcl-xL/Bcl-2-associated death promoter, Bcl2 antagonist of cell death, Bcl2-L-8

7 Images
Immunoprecipitation - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)
  • IP

Lab

Immunoprecipitation - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)

ab129192 (purified) at 1/30 immunoprecipitating Bad in HeLa cell lysate treated with Calcyculin A (Lane 1). For western blotting a HRP-conjugated anti-rabbit IgG was used as the secondary antibody (1/1000).

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-Bad (phospho S112) antibody [EPR1891(2)] (ab129192)

Predicted band size: 18 kDa

false

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)
  • WB

Unknown

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)

All lanes:

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (ab129192) at 1/1000 dilution

Lane 1:

HeLa cell lysates, untreated at 10 µg

Lane 2:

HeLa cell lysates, treated with Calyculin A at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 18 kDa

false

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)
  • WB

Lab

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)

Blocking and diluting buffer and concentration : 5% NFDM/TBST

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) 1 : 1,000,000 dilution

This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.

All lanes:

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (ab129192) at 1/1000 dilution

Lane 1:

Untreated HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate. (Untreated membrane) at 20 µg

Lane 2:

HeLa treated with 100 ng/ml Calyculin A for 30 min whole cell lysate. (Untreated membrane) at 20 µg

Lane 3:

HeLa treated with 100 ng/ml Calyculin A for 30 min whole cell lysate. (Phosphatase treated membrane) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 23 kDa

true

Exposure time: 180s

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)
  • WB

Lab

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)

Blocking buffer : 5% NFDM/TBST

Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (ab129192) at 1/20000 dilution

Lane 1:

Untreated HeLa cell lysate at 10 µg

Lane 2:

HeLa cell lysate treated with Calcyculin A at 10 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 18 kDa

Observed band size: 23 kDa

false

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)
  • WB

Lab

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)

Blocking buffer : 5% NFDM/TBST

Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (ab129192) at 1/5000 dilution

Lane 1:

Untreated C6 cells at 10 µg

Lane 2:

C6 cells treated with Calcyculin A at 10 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 18 kDa

Observed band size: 23 kDa

false

Dot Blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)
  • Dot

Lab

Dot Blot - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)

Dot blot analysis of Bad (phospho S112) using ab129192 primary antibody at a dilution of 1/1000. ab97051 was used as a secondary antibody at a dilution of 1/100000.

Lane 1 : Bad (pS112) phospho peptide
Lane 2 : Bad non-phospho peptide

Blocking and diluting buffer : 5% NFDM/TBST

OI-RD Scanning - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Bad (phospho S112) antibody [EPR1891(2)] (AB129192)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR1891(2)

Isotype

IgG

Carrier free

No

Reacts with

Rat, Human

Applications

WB, Dot, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "Dot-species-checked": "predicted", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Synthetic peptide": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/500", "Dot-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Bad protein also known as Bcl-2-associated death promoter plays a critical role in apoptosis regulation. It possesses a molecular weight of approximately 23 kDa. Bad is expressed widely in tissues and is a member of the Bcl-2 family of proteins. This family is well-known for its involvement in the regulation of cell death both promoting and inhibiting depending on the protein’s interactions.
Biological function summary

Its main role is to promote apoptosis by binding to anti-apoptotic proteins like Bcl-2 and Bcl-XL displacing pro-apoptotic Bax and Bak proteins to trigger cell death. Bad functions as part of the mitochondrial apoptosis pathway and is known to form complexes with phosphorylated proteins. Phosphorylation of Bad by kinases can lead to its sequestration to the cytoplasm reducing apoptosis.

Pathways

Its action is pivotal in the PI3K/Akt signaling pathway. This pathway involves growth factors and cell survival signals where phosphorylation of Bad inhibits its pro-apoptotic activity. Bad interacts with proteins like Akt and 14-3-3 to modulate cell survival. Disruption in its regulation through these pathways may lead to abnormal cell survival or death.

Bad has implications in cancer and neurodegenerative diseases. Cancer cells often exhibit impaired apoptotic pathways where overexpression of Bad can ameliorate responsiveness to therapy. In neurodegenerative diseases such as Alzheimer's dysregulation of its function can contribute to cell death. The protein’s interaction with Bcl-2 and Bcl-XL is significant in these contexts influencing disease propagation and severity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Promotes cell death. Successfully competes for the binding to Bcl-X(L), Bcl-2 and Bcl-W, thereby affecting the level of heterodimerization of these proteins with BAX. Can reverse the death repressor activity of Bcl-X(L), but not that of Bcl-2 (By similarity). Appears to act as a link between growth factor receptor signaling and the apoptotic pathways.
See full target information BAD phospho S112

Publications (25)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 26: PubMed40565356

2025

Pro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1-benzimidazol-1-yl)propan-2-one, an Intracellular Inhibitor of PIM-1 Kinase in Acute Lymphoblastic Leukemia and Breast Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Patrycja Wińska,Monika Wielechowska,Łukasz Milewski,Paweł Siedlecki,Edyta Łukowska-Chojnacka

Advances in pharmacological and pharmaceutical sciences 2024:2653426 PubMed39544485

2024

Saikosaponin-b2 Regulates the Proliferation and Apoptosis of Liver Cancer Cells by Targeting the MACC1/c-Met/Akt Signalling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yanxue Zhu,Xingzhi Lv,Ruifang Li,Zihan Gao,Chanhao Lei,Lan Wang,Sanqiang Li

Cell reports 42:113184 PubMed37776520

2023

Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Heather L Martin,Amy L Turner,Julie Higgins,Anna A Tang,Christian Tiede,Thomas Taylor,Sitthinon Siripanthong,Thomas L Adams,Iain W Manfield,Sandra M Bell,Ewan E Morrison,Jacquelyn Bond,Chi H Trinh,Carolyn D Hurst,Margaret A Knowles,Richard W Bayliss,Darren C Tomlinson

Molecules (Basel, Switzerland) 28: PubMed37049702

2023

Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin Resistance by Regulating AEG-1 Abundance in Breast Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Junying Song,Cuixiu Peng,Runze Wang,Yanan Hua,Qinglan Wu,Lin Deng,Yi Cao,Li Zhang,Lin Hou

Cell death and differentiation 30:195-207 PubMed36171331

2022

Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Kaixuan Shi,Haijiao Lu,Zhenfeng Zhang,Yujie Fu,Jie Wu,Shichao Zhou,Pengfei Ma,Kaiyan Ye,Shengzhe Zhang,Hailei Shi,Weiping Shi,Mei-Chun Cai,Xiaojing Zhao,Zhuang Yu,Jian Tang,Guanglei Zhuang

Stem cells international 2022:9806887 PubMed36199627

2022

Erythropoietin Activates Autophagy to Regulate Apoptosis and Angiogenesis of Periodontal Ligament Stem Cells via the Akt/ERK1/2/BAD Signaling Pathway under Inflammatory Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Denghao Huang,Jie Lei,Xingrui Li,Zhonghao Jiang,Maoxuan Luo,Yao Xiao

Oncology letters 24:289 PubMed35928803

2022

miR-29b-3p inhibits 22Rv1 prostate cancer cell proliferation through the YWHAE/BCL-2 regulatory axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jiafu Zhao,Xiaoyan Ma,Houqiang Xu

Frontiers in oncology 11:727605 PubMed34513705

2021

Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress.

Applications

Unspecified application

Species

Unspecified reactive species

Anhui Yang,Zhen Sun,Rui Liu,Xin Liu,Yue Zhang,Yulin Zhou,Ye Qiu,Xinrui Zhang

Aging 13:14219-14233 PubMed33988127

2021

LncRNA AK020546 protects against cardiac ischemia-reperfusion injury by sponging miR-350-3p.

Applications

Unspecified application

Species

Unspecified reactive species

Meiqi Zhang,Kang Cheng,Huan Chen,Jianfeng Tu,Ye Shen,Lingxiao Pang,Weihua Wu,Zhenfei Yu

Experimental and therapeutic medicine 21:486 PubMed33790995

2021

Klotho overexpression suppresses apoptosis by regulating the Hsp70/Akt/Bad pathway in H9c2(2-1) cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jinpeng Hu,Bin Su,Xuewen Li,Yuming Li,Jihong Zhao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com